Get started

MSD (Turkiye)

Homepage: msd.com.tr
Alternate names: MSD Turkey, MSD Türkiye, Merck Sharp & Dohme Turkey, Merck Sharp & Dohme Turkiye
ROR: 05p0kyc43
OpenAlex ID: I4405252622
Cost-effectiveness analysis of universal varicella vaccination in Turkey using a dynamic transmission model
2019 · Lara J. Wolfson, Vincent J. Daniels, et al. · PLoS ONE · 35
PDF
GO-BEYOND: A Real-World Study of Persistence of Golimumab in Patients with Axial Spondyloarthritis and Rheumatoid Arthritis in Turkey
2021 · Servet Akar, Umut Kalyoncu, et al. · Immunotherapy · 10
The cost-effectiveness of treatment for high-risk, early-stage, triple-negative breast cancer in Egypt: an analysis of neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant single-agent pembrolizumab
2024 · Bernadette Pöllinger, Amin Haiderali, et al. · Journal of Medical Economics · 4
BVDV monitoring by pooling and real time RT-PCR as economical monitoring technique with low BVDV prevalence
2022 · Hikmet ÜN, Mustafa GÖKÇE, et al. · Journal of Advances in VetBio Science and Techniques · 3
PDF
Estimation of hepatitis C costs in turkey VIA expert opinion: Delphi panel
2014 · N. Ormeci, U. Akarca, et al. · Value in Health · 2
Exploring 3rd Graders’ Informal Science Learning Experiences in the Schoolyard: A Qualitative Study
2026 · Demet Yildiz, Nihal Dogan · Tecné Episteme y Didaxis TED · 1
PDF
Evaluation of implementation of evolving practice patterns in the first-line treatment of patients with metastatic non-small cell lung cancer in Turkiye (ESTIMATE): a national, multicenter, retrospective, real-world evidence study
2025 · Mehmet Ali Nahit Sendur, Nuri Karadurmus, et al. · Future Oncology · 1
EE286 Cost Effectiveness and Public Health Impact of Implementing Gender-Neutral Vaccination with the 9-Valent Human Papillomavirus Vaccine in Turkiye
2023 · B. Akyol Ersoy, E. Koç, et al. · Value in Health · 1
PDF
EE193 The Health Impact Projection Model of the PD-1/PD-L1 Inhibitor Class in Cancer Care in Turkey
2022 · U Akpamuk, R Hughes, et al. · Value in Health · 1
PDF
EPH236 The Health Impact of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Single-Agent Pembrolizumab Treatment for High-Risk Early Stage Triple-Negative Breast Cancer (eTNBC) in Türkiye
2025 · Burcu Akyol Ersoy, Yasemin Ceylan, et al. · Value in Health
EPH237 The Health Impact of Pembrolizumab for the First-Line Treatment for Metastatic Non-Small Cell Lung Cancer (mNSCLC) That Expresses High Levels of PD-L1 in Türkiye
2025 · Burcu Akyol Ersoy, Yasemin Ceylan, et al. · Value in Health
EPH240 The Health Impact of Pembrolizumab Plus Chemotherapy in the First-Line Treatment for Metastatic Triple-Negative Breast Cancer (TNBC) in Türkiye
2025 · Burcu Akyol Ersoy, Yasemin Ceylan, et al. · Value in Health
EPH239 The Health Impact of Pembrolizumab in Combination With Chemotherapy for the First-Line Treatment of Patients With Squamous Metastatic Non-Small Cell Lung Cancer (mNSCLC) in Türkiye
2025 · Burcu Akyol Ersoy, Yasemin Ceylan, et al. · Value in Health
EPH238 The Health Impact of Pembrolizumab in Combination With Chemotherapy for the First-Line Treatment of Patients With Nonsquamous Metastatic Non-Small Cell Lung Cancer (mNSCLC) in Türkiye
2025 · Burcu Akyol Ersoy, Yasemin Ceylan, et al. · Value in Health
Antifungal prophylaxis in high-risk patients with hematologic malignancy:a comparison of practice with guidelines in Türkiye
2025 · ÖZLEM GÜZEL TUNÇCAN, SEÇKİN ÇAĞIRGAN, et al. · TURKISH JOURNAL OF MEDICAL SCIENCES
EE217 Cancer-Related Mortality in Turkiye: Years of Life Lost and Productivity Costs
2023 · B. Akyol Ersoy, N. Karadurmuş, et al. · Value in Health
PIN24 Budget Analysis of Turkish National Immunization Program
2020 · E. Koç, G. Bencina · Value in Health
Comparison of Sugammadex and Neostigmine Use in Terms of Cost Savings in Hospitals in Turkish Healthcare Setting
2016 · M. Tatar, E. Tuna, et al. · Value in Health
PDF
The Sources of Transition Probabilities in Turkish Labour Market: An Empirical Evidence for Overlapping Individual Data, 2007- 2008
2014 · yılmaz ekşi, gülser pınar, AKDI, YILMAZ, et al. · Journal of economic cooperation and development
Estimating the Cost of HPV-Related Diseases in Turkey: A Delphi Approach
2013 · M. Bakir, A. Ayhan, et al. · Value in Health
Works count: 20
Citation count: 86
Year
Topic
Type